The Changes of Treg Cells Frequency and Function During Antiviral Therapy
NCT03210493
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B Infection
Interventions
DRUG:
Peginterferon Alfa-2a
Sponsor
Beijing Ditan Hospital